Stem Cell-Derived Motoneurons in the Adult mammalian CNS

成年哺乳动物中枢神经系统中干细胞衍生的运动神经元

基本信息

批准号：
7216197
负责人：
DOUGLAS A KERR
金额：
$ 35.91万
依托单位：
JOHNS HOPKINS UNIVERSITY
依托单位国家：
美国
项目类别：
财政年份：
2005
资助国家：
美国
起止时间：
2005-02-01 至 2009-01-31
项目状态：
已结题

来源：
https://reporter.nih.gov/project-details/7216197
关键词：
Acute Adult Affect Agonist Amyotrophic Lateral Sclerosis Animal Experiments Animals Area Axon Biology Brain-Derived Neurotrophic Factor Cell Differentiation process Cell Separation Cell Survival Cell Transplants Cells Chemicals Chronic Commit Cues Cyclic AMP Cyclodextrins Cyclooxygenase Inhibitors Denervation Disease Dissociation Distal Edetic Acid Effectiveness Environment Erinaceidae Excitatory Amino Acid Antagonists Exhibits Generations Glutamates Goals Growth Histologic Individual Injury Insulin-Like Growth Factor I Intramuscular Label Ligands Mediating Minocycline Mitotic Modeling Modification Molecular Motor Motor Neurons Muscle Myelin NGFR gene Nerve Growth Factor Receptors Nervous system structure Neuroglia Neuromuscular Junction Neuronal Injury Neurons Nitric Oxide Numbers Papain Paralysed Peptides Peripheral Nerves Peripheral Nervous System Pluripotent Stem Cells Preparation Prostaglandins Protein Overexpression Proteins Protocols documentation Rattus Reactive Oxygen Species Reporting Research Personnel Rho-associated kinase Riluzole Rodent Model Series Signal Transduction Skeletal Muscle Small Interfering RNA Spinal Spinal Cord Spinal cord damage Spinal cord injury Staging Stem cells Surface Testing Thalidomide Time Transplantation Tretinoin Trypsin Ventral Roots Viral adeno-associated viral vector aminoguanidine axon growth base behavior test celecoxib collagenase conditioning embryonic stem cell in vivo inhibitor/antagonist injured kinase inhibitor nerve stem cell neurotrophic factor novel strategies progenitor programs receptor reconstitution relating to nervous system response sciatic nerve small molecule success transgene expression white matter

项目摘要

DESCRIPTION (provided by applicant): We have found that motoneuron-differentiated ES cells survive when transplanted into adult rats with a motoneuron injury and that many of the cells exhibit immunohistochemical features of mature motoneurons. In this project, we will determine strategies that facilitate the generation of functional ES cell-derived motoneurons in the injured adult, mammalian CNS. In specific aim 1, we will define host-applied and ex vivo strategies that optimize motoneuron differentiation and survival in the acutely damaged spinal cord. We will determine the ability of these cells to survive and engraft within the rat spinal cord at each of several differentiation stages (i.e. pluripotent stem cell, committed neural precursor, committed motoneuron precursor or postmitotic motoneuron). Additionally, we will explore whether the environment into which the cells are transplanted modulates survival and differentiation. In specific aim 2, we will test approaches that enhance the ability of ES cell-derived axons to overcome CNS white matter-mediated axonal repulsion. We will modulate the activity of NOGO-R, P75-NTR and RhoA in order to transiently render the transplanted ES cells less susceptible to host repulsive cues as they navigate surrounding white matter. In specific aim 3, we will test approaches that enhance the ability of ES cell-derived motoneurons to extend axons distally and allow the formation of functional neuromuscular junctions in vivo. Based on expression of neurotrophin receptors on ES-derived motoneurons, we propose to peripherally express cognate ligands (including IGF-1 and GDNF) that will attract ES-cell derived motor axons to grow distally and to innervate muscle. Retrograde labeling, electrophysiologic testing and behavioral studies will determine the effectiveness of these strategies in generating functional motoneurons and restoring motor units in paralyzed animals. These studies will define an important transplantation approach for motoneuron disease such as ALS and SMA and for spinal cord injury and other spinal disorders.

描述（由申请人提供）：我们发现运动神经元分化的 ES 细胞在移植到运动神经元损伤的成年大鼠中时能够存活，并且许多细胞表现出成熟运动神经元的免疫组织化学特征。在这个项目中，我们将确定促进在受伤的成年哺乳动物中枢神经系统中生成功能性 ES 细胞衍生运动神经元的策略。在具体目标 1 中，我们将定义宿主应用和离体策略，以优化严重受损脊髓中运动神经元的分化和存活。我们将确定这些细胞在几个分化阶段（即多能干细胞、定型神经前体、定型运动神经元前体或有丝分裂后运动神经元）的每个阶段存活和移植到大鼠脊髓内的能力。此外，我们将探讨细胞移植的环境是否调节存活和分化。在具体目标 2 中，我们将测试增强 ES 细胞衍生轴突克服 CNS 白质介导的轴突排斥能力的方法。我们将调节 NOGO-R、P75-NTR 和 RhoA 的活性，以便暂时使移植的 ES 细胞在导航周围白质时不易受到宿主排斥信号的影响。在具体目标 3 中，我们将测试增强 ES 细胞来源的运动神经元向远端延伸轴突并允许在体内形成功能性神经肌肉接头的能力的方法。基于神经营养蛋白受体在 ES 衍生的运动神经元上的表达，我们建议外周表达同源配体（包括 IGF-1 和 GDNF），这些配体将吸引 ES 细胞衍生的运动轴突向远端生长并神经支配肌肉。逆行标记、电生理测试和行为研究将确定这些策略在产生功能性运动神经元和恢复瘫痪动物运动单位方面的有效性。这些研究将为 ALS 和 SMA 等运动神经元疾病以及脊髓损伤和其他脊柱疾病确定重要的移植方法。